CDK5 and Alzheimer disease: However, deregulation, in particular, hyper-activation of Cdk5 is one key contributor to the pathogenesis of some neurodegenerative diseases including Alzheimer’s disease (AD) and Parkinson’s disease (PD)[3,4].